The Pulmonary/Respiratory Drug Delivery market was valued at USD 60.13 Million in 2023 and is expected to reach USD 99.52 Million by 2031, growing at a CAGR of 6.5% (2024-2031). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.